生存率-话题@MedSci

#生存率#

482篇内容 | 2857人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1256865, encodeId=77f0125686548, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=2020年ASCO-SITC：恶病质与接受Pembrolizumab的晚期肺癌患者的生存率相关, objectType=article, longId=221034, objectId=5e2522103406, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e2522103406, replyNumber=0, likeNumber=72, createdTime=2021-11-27, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e2522103406, moduleTitle=2020年ASCO-SITC：恶病质与接受Pembrolizumab的晚期肺癌患者的生存率相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e2522103406)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256864, encodeId=9c88125686499, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Leukemia：浆细胞疾病家族史与 MGUS、多发性骨髓瘤和系统性 AL 淀粉样变性的生存率提高有关, objectType=article, longId=220763, objectId=d703220e63d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d703220e63d2, replyNumber=0, likeNumber=126, createdTime=2021-11-23, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d703220e63d2, moduleTitle=Leukemia：浆细胞疾病家族史与 MGUS、多发性骨髓瘤和系统性 AL 淀粉样变性的生存率提高有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d703220e63d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256863, encodeId=3034125686343, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=AJKD：系统性红斑狼疮患者肾脏替代治疗后的生存率和预后调查, objectType=article, longId=220346, objectId=b32c22034692, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b32c22034692, replyNumber=0, likeNumber=0, createdTime=2021-11-16, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b32c22034692, moduleTitle=AJKD：系统性红斑狼疮患者肾脏替代治疗后的生存率和预后调查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b32c22034692)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256862, encodeId=26241256862cf, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Prostate：体外放射治疗是否影响前列腺癌老年患者的生存率？, objectType=article, longId=219904, objectId=f023219904e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f023219904e8, replyNumber=0, likeNumber=55, createdTime=2021-11-08, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f023219904e8, moduleTitle=Prostate：体外放射治疗是否影响前列腺癌老年患者的生存率？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f023219904e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256861, encodeId=1c781256861bb, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAHA：神经激素阻断与甲状腺素运载蛋白心脏淀粉样变性患者生存率无关, objectType=article, longId=219773, objectId=a363219e736a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a363219e736a, replyNumber=0, likeNumber=63, createdTime=2021-11-05, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a363219e736a, moduleTitle=JAHA：神经激素阻断与甲状腺素运载蛋白心脏淀粉样变性患者生存率无关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a363219e736a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256860, encodeId=06141256860ea, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Neurology：左乙拉西坦使用时间对成人异柠檬酸脱氢酶野生型胶质母细胞瘤总生存率影响的观察研究, objectType=article, longId=219464, objectId=7756219464f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7756219464f4, replyNumber=0, likeNumber=50, createdTime=2021-10-30, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7756219464f4, moduleTitle=Neurology：左乙拉西坦使用时间对成人异柠檬酸脱氢酶野生型胶质母细胞瘤总生存率影响的观察研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7756219464f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256859, encodeId=3e6112568595a, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J Urol：在高危和极高危前列腺癌患者中，根治性前列腺切除术与放射治疗哪个生存率更高？, objectType=article, longId=218837, objectId=989a21883e0b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=989a21883e0b, replyNumber=0, likeNumber=92, createdTime=2021-10-20, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=989a21883e0b, moduleTitle=J Urol：在高危和极高危前列腺癌患者中，根治性前列腺切除术与放射治疗哪个生存率更高？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=989a21883e0b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256858, encodeId=f1a81256858ad, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Imfinzi联合tremelimumab治疗肝癌，III期试验显示可提高总体生存率, objectType=article, longId=218686, objectId=4c14218686ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c14218686ce, replyNumber=0, likeNumber=52, createdTime=2021-10-17, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c14218686ce, moduleTitle=Imfinzi联合tremelimumab治疗肝癌，III期试验显示可提高总体生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c14218686ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256857, encodeId=1658125685e80, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=EHJ：三血管疾病患者，使用全新技术PCI术后明显改善生存率！, objectType=article, longId=218413, objectId=284d218413e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=284d218413e6, replyNumber=0, likeNumber=83, createdTime=2021-10-13, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=284d218413e6, moduleTitle=EHJ：三血管疾病患者，使用全新技术PCI术后明显改善生存率！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=284d218413e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256856, encodeId=800c12568568a, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=BJH：供体端粒长度对患有再生障碍性贫血的同胞供体移植患者生存率的影响, objectType=article, longId=218176, objectId=66902181e63f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66902181e63f, replyNumber=0, likeNumber=127, createdTime=2021-10-08, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66902181e63f, moduleTitle=BJH：供体端粒长度对患有再生障碍性贫血的同胞供体移植患者生存率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66902181e63f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256855, encodeId=9b141256855c3, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Anesthesiology：不可切除胰腺癌患者行神经毁损性内脏神经阻滞与患者疼痛缓解、生存率和生活质量的关系：一项随机对照试验, objectType=article, longId=217971, objectId=9e3021e9717d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e3021e9717d, replyNumber=0, likeNumber=68, createdTime=2021-10-02, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e3021e9717d, moduleTitle=Anesthesiology：不可切除胰腺癌患者行神经毁损性内脏神经阻滞与患者疼痛缓解、生存率和生活质量的关系：一项随机对照试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e3021e9717d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256854, encodeId=6ed812568541b, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Clinical Gastroenterology Hepatology: 二甲双胍对糖尿病和肝硬化患者生存率的影响, objectType=article, longId=217649, objectId=f7b621e649bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7b621e649bb, replyNumber=0, likeNumber=65, createdTime=2021-09-27, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7b621e649bb, moduleTitle=Clinical Gastroenterology Hepatology: 二甲双胍对糖尿病和肝硬化患者生存率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7b621e649bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256853, encodeId=2fc11256853da, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Neurology：多发性硬化症患者结直肠癌生存率, objectType=article, longId=217263, objectId=19d921e2630a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19d921e2630a, replyNumber=0, likeNumber=79, createdTime=2021-09-19, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19d921e2630a, moduleTitle=Neurology：多发性硬化症患者结直肠癌生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19d921e2630a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256852, encodeId=f17b12568528b, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA |我国学者：卡瑞丽珠单抗降低晚期食管癌患者3成生存率、4成无进展生存！, objectType=article, longId=217252, objectId=af4221e2529b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af4221e2529b, replyNumber=0, likeNumber=78, createdTime=2021-09-19, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af4221e2529b, moduleTitle=JAMA |我国学者：卡瑞丽珠单抗降低晚期食管癌患者3成生存率、4成无进展生存！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af4221e2529b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256851, encodeId=646a12568518a, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=纤维化性间质性肺病患者住院或门诊肺康复治疗后的生存率-多中心回顾性队列研究, objectType=article, longId=217114, objectId=a51121e1148d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a51121e1148d, replyNumber=0, likeNumber=64, createdTime=2021-09-16, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a51121e1148d, moduleTitle=纤维化性间质性肺病患者住院或门诊肺康复治疗后的生存率-多中心回顾性队列研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a51121e1148d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256850, encodeId=783e125685017, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J Thromb Haemost：院前抗血小板治疗与COVID-19住院患者生存率之间的关联, objectType=article, longId=217001, objectId=898721e001dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=898721e001dc, replyNumber=0, likeNumber=69, createdTime=2021-09-14, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=898721e001dc, moduleTitle=J Thromb Haemost：院前抗血小板治疗与COVID-19住院患者生存率之间的关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=898721e001dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256849, encodeId=fff9125684930, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Eur Heart J：Takayasu动脉炎相关肺动脉高压的临床特征和生存率, objectType=article, longId=216965, objectId=0e322169655d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e322169655d, replyNumber=0, likeNumber=72, createdTime=2021-09-13, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e322169655d, moduleTitle=Eur Heart J：Takayasu动脉炎相关肺动脉高压的临床特征和生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e322169655d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256848, encodeId=00061256848ed, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=DCR: 围手术期输血不能改变直肠癌根治性切除术后的总体生存率, objectType=article, longId=216329, objectId=f50121632919, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f50121632919, replyNumber=0, likeNumber=93, createdTime=2021-08-27, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f50121632919, moduleTitle=DCR: 围手术期输血不能改变直肠癌根治性切除术后的总体生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f50121632919)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256847, encodeId=b735125684e7f, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Frontiers in Oncology：双管齐下：化疗减瘤+CAR-T治疗，提高高肿瘤负荷淋巴瘤患者缓解率和总生存率, objectType=article, longId=215868, objectId=a06721586815, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a06721586815, replyNumber=0, likeNumber=57, createdTime=2021-08-18, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a06721586815, moduleTitle=Frontiers in Oncology：双管齐下：化疗减瘤+CAR-T治疗，提高高肿瘤负荷淋巴瘤患者缓解率和总生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a06721586815)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256846, encodeId=215912568460d, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA：生理盐水vs平衡晶体液静脉输注对ICU患者90天生存率的影响, objectType=article, longId=215614, objectId=aff6215614b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aff6215614b7, replyNumber=0, likeNumber=67, createdTime=2021-08-13, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aff6215614b7, moduleTitle=JAMA：生理盐水vs平衡晶体液静脉输注对ICU患者90天生存率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aff6215614b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生存率

2020-05-29

guoyibin (审核中...)

前往app查看评论内容

#生存率#

2020年ASCO-SITC：恶病质与接受Pembrolizumab的晚期肺癌患者的生存率相关

2021-11-27

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Leukemia：浆细胞疾病家族史与 MGUS、多发性骨髓瘤和系统性 AL 淀粉样变性的生存率提高有关

2021-11-23

guoyibin (审核中...)

前往app查看评论内容

#生存率#

AJKD：系统性红斑狼疮患者肾脏替代治疗后的生存率和预后调查

2021-11-16

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Prostate：体外放射治疗是否影响前列腺癌老年患者的生存率？

2021-11-08

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAHA：神经激素阻断与甲状腺素运载蛋白心脏淀粉样变性患者生存率无关

2021-11-05

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Neurology：左乙拉西坦使用时间对成人异柠檬酸脱氢酶野生型胶质母细胞瘤总生存率影响的观察研究

2021-10-30

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J Urol：在高危和极高危前列腺癌患者中，根治性前列腺切除术与放射治疗哪个生存率更高？

2021-10-20

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Imfinzi联合tremelimumab治疗肝癌，III期试验显示可提高总体生存率

2021-10-17

guoyibin (审核中...)

前往app查看评论内容

#生存率#

EHJ：三血管疾病患者，使用全新技术PCI术后明显改善生存率！

2021-10-13

guoyibin (审核中...)

前往app查看评论内容

#生存率#

BJH：供体端粒长度对患有再生障碍性贫血的同胞供体移植患者生存率的影响

2021-10-08

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Anesthesiology：不可切除胰腺癌患者行神经毁损性内脏神经阻滞与患者疼痛缓解、生存率和生活质量的关系：一项随机对照试验

2021-10-02

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Clinical Gastroenterology Hepatology: 二甲双胍对糖尿病和肝硬化患者生存率的影响

2021-09-27

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Neurology：多发性硬化症患者结直肠癌生存率

2021-09-19

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAMA |我国学者：卡瑞丽珠单抗降低晚期食管癌患者3成生存率、4成无进展生存！

2021-09-19

guoyibin (审核中...)

前往app查看评论内容

#生存率#

纤维化性间质性肺病患者住院或门诊肺康复治疗后的生存率-多中心回顾性队列研究

2021-09-16

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J Thromb Haemost：院前抗血小板治疗与COVID-19住院患者生存率之间的关联

2021-09-14

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Eur Heart J：Takayasu动脉炎相关肺动脉高压的临床特征和生存率

2021-09-13

guoyibin (审核中...)

前往app查看评论内容

#生存率#

DCR: 围手术期输血不能改变直肠癌根治性切除术后的总体生存率

2021-08-27

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Frontiers in Oncology：双管齐下：化疗减瘤+CAR-T治疗，提高高肿瘤负荷淋巴瘤患者缓解率和总生存率

2021-08-18

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAMA：生理盐水vs平衡晶体液静脉输注对ICU患者90天生存率的影响

2021-08-13

科室
- - 订阅+
  - 更多科室
工具
服务